心血管疾病的时间治疗

摘要/Abstract

中图分类号:

王颢, 原卫清, 吕卓人. 心血管疾病的时间治疗[J]. 中国临床药理学与治疗学, 1997, 2(3): 224-228.

1 Tolstoil G.A review of chronobiology and chronopharmacology.J Pract Nurs, 1994, 44(1):47
2 Weinert D,Sitka U,Minors DS, et al.The development of circadianrhy thmicity in neonates.Early Hum Dev, 1994, 36(2):117
3 Janssen BJ, Tyssen CM, Duindam H, et al.Suprachiasmatic lesions eliminate 24-h blood pressure variability in rats.physiol Behav, 1994,55(2):307
4 Andreotti F, Davies GJ, Hackett DR, et al.Major circadian fluctuations in fibrinolytic factors and possibler elevance to time of onset of myo cardial inf arction, sudden cardiac death and stroke.Am J Cardiol, 1988,62:635
5 Krantz DS, Kop JW, Gabbay FH, et al.Circadian variation of ambulatory my ocardial ischemia:triggering by daily activities and evidence for an endo genous circadian component.Circulation, 1996, 93:1364
6 Moser DK, Stevenson WG, Woo MA, et al.Timing of sudden death in patients with heart failure.J Am Coll Cardiol, 1994,24:9 63
7 Lampert R, Ro senfeld L, Batsford W, et al.Circadian variation of sustained vent ricular tachy cardia in patients with cor onary a rtery disease and implantable cardiover terdefibrillators.Circulation, 1994,90:2 41
8 Panza JA, Epstein SE, Quyyumi AA.Circadian variation in vascular tone and its relation to alpha-sympa thetic vasoconstrictor activity.N Engl J Med, 1991,325:986
9 Middlekauff HR, Sontz EM.Morning sympa Theticner vactivity is not increased in humans: implications for mechamnisms under lying the circadian pattern of cardiac risk.Circulation, 1995,91:2549
10 Muller JE, Abela GS, Nestor W, et al.Triggers, acute risk factors and vulnerable plaques:The lexicon of a new frontier.J Am Coll Cardiol,1994,23:809
11 Brezinski DA, Tofler GH, Muller JE, et al.Morning increase in platele tag greg ability:association with a ssumption of the upright posture.Circulation, 1988,78:35
12 Umeda T, Naomi S, Iwaoka T, et al.Timing for administ ration of an antihypertensive drug in the treatment of essential hype rtension.Hyper tension, 1994,23(suppl Ⅰ): Ⅰ-211
13 杨藻寰, 主编.药理学总论.北京:人民卫生出版社,1986:538
14 严文魁, 柯永胜, 王安才, 等.健康人血清内源性洋地黄样因子的动态变化.中国循环杂志, 1992, 7:342
15 Aronow WS, Ahn C, Mercando AD, et al.Circadian variation of sudden cardiac death or fatal my ocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular a rrhy thmias.Am J Cardiol, 1994, 74:819
16 Andrews TC, Fenton T, Toyosaki N, et al.Subsedt of ambulatory my ocardial ischemia based on heart rate activity:circadian distribution and response to anti-ischemic medication.Circulation, 1993,88:92
17 Langner B, Lemmer B.Circadian changes in the Pharma cokinetics and cardiov ascular Effects of oral propranolol in healthy subjects.Eur J Clin Parmacol, 1988,33:6 19
18 Parmley WW, Nestor W, Singh BN, et al.Attenuation of the circadian patterns of my ocardial ischemia with nifedipine G TTS in patients with chronic stable angina.J Am Coll Cardiol, 1992,19:1 380
19 Nestor W, Phillips RT, Kett KG, et al.effect of nifedipine on total ischemic activity and circadian distribution of my ocardial ischemic episodes in anginapectoris.Am J Cardiol, 1991, 67:128
20 Bridges AB, Scott NA, Mc Neill GP, et al.Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease.Eurheart J, 1992, 13:1 632
21 Ridker PM, Manson JAE, Buring JE, et al.Circadian variation of acute my ocardial infarction and the effect of low-dose aspirin in aradomized trial of phy sicians.Circulation, 1990,82:897
22 Kurnik PB.Circadian variation in The efficacy of tissue-typeplasmino genactivator.Circulation, 1995,91:1341
23 Braunwald E.Morning resistance to thrombolytic therapy.Circulation, 1995,91:1604
24 Hjalmarson A, Gilpin EA, Nicod P, et al.Differing circadian patterns of symptom onset in subgroups of patients with a cute infection.Circulation, 1989,80:267

[1]	曹雪芬, 冷玉芳, 韩晓霞, 侯小煜, 吕兴娇, Janvier NIBARUTA. 川芎嗪通过抑制NLRP3减轻肠缺血再灌注损伤的细胞焦亡[J]. 中国临床药理学与治疗学, 2023, 28(11): 1201-1208.
[2]	王剑, 孙永东, 周兴玮, 刘雷, 陈龙, 童兴科, 朱佳丽. 黄芩素经由miR-125b-5p/IRF4轴进而促进喉癌细胞死亡并抑制其侵袭的机制研究[J]. 中国临床药理学与治疗学, 2023, 28(11): 1209-1218.
[3]	朱瑞芳, 郭东凯, 智慧, 江翊国, 张悦翎, 钱晓萍, 季士亮. ROS-NF-κB-p38MAPK通路探索榄香烯联合硼替佐米抗多发性骨髓瘤的机制研究[J]. 中国临床药理学与治疗学, 2023, 28(11): 1219-1226.
[4]	李菲, 丁慧琴, 陈梦静. 异莲心碱激活ERK信号通路诱导肺癌PC9细胞自噬的作用研究[J]. 中国临床药理学与治疗学, 2023, 28(11): 1235-1240.
[5]	石丹丹, 孙祎尧, 陈晓琦, 杨芳明, 张传雷, 王新亭, 袁长威, 陈欣菊. 扶正消瘤颗粒治疗原发性肝癌的疗效观察及血清代谢组学分析[J]. 中国临床药理学与治疗学, 2023, 28(11): 1247-1262.
[6]	卢克鹏, 刘彩虹, 毕莹. 预防性抗凝持续时间对全髋/膝关节置换术后静脉血栓形成的影响[J]. 中国临床药理学与治疗学, 2023, 28(11): 1269-1274.
[7]	刘璐, 石雨菲, 何庆烽, 徐凤艳, 王鲲, 蔡卫民, 相小强. 群体模型分析方法评估基因多态性对药物PK/PD的影响[J]. 中国临床药理学与治疗学, 2023, 28(11): 1275-1282.
[8]	刘兆丰, 李玲, 那淑芳, 乐江, 叶啟发. 法尼酯X受体翻译后修饰调控机制研究进展[J]. 中国临床药理学与治疗学, 2023, 28(11): 1292-1298.
[9]	陈玉林, 蒋虎刚, 王新强, 刘凯, 李应东, 安涛, 赵信科. 基于网络药理学和分子对接探讨芪参益心颗粒治疗射血分数保留型心力衰竭的作用机制[J]. 中国临床药理学与治疗学, 2023, 28(10): 1081-1092.
[10]	王秀, 季麒麟, 裴文俊, 曾颖. 3-溴丙酮酸-胆固醇酯增强乳腺癌细胞对他莫昔芬敏感性研究[J]. 中国临床药理学与治疗学, 2023, 28(10): 1093-1100.
[11]	衡冰冰, 杨丹峰, 戴舒阳, 上官王宁. 丙泊酚对皮下注射氯喹所致瘙痒大鼠脊髓TRPV1和CB1受体的影响[J]. 中国临床药理学与治疗学, 2023, 28(10): 1101-1108.
[12]	贾博颖, 周双, 万里燕, 周颖, 崔一民. 基于FAERS的老年患者药源性吞咽障碍信号挖掘研究[J]. 中国临床药理学与治疗学, 2023, 28(10): 1109-1120.
[13]	李雪静, 江金平, 李思凝, 万林飞, 周响响, 杨梿, 兰轲. 一项在中国精神分裂症受试者中评估氯氮平片的生物等效性研究[J]. 中国临床药理学与治疗学, 2023, 28(10): 1121-1130.
[14]	刘敏, 孔祥, 章叶, 顾逸飞, 项雪梅, 黄凯. 经口吸入制剂在中国健康受试者生物等效性试验中的安全性分析[J]. 中国临床药理学与治疗学, 2023, 28(10): 1131-1138.
[15]	廖梦玲, 汪艳, 罗静, 王诺妍, 华玲, 张瑜, 邓非, 袁月, 周军, 周红. 青蒿琥酯抑制巨噬细胞释放前炎症细胞因子的分子作用机制研究[J]. 中国临床药理学与治疗学, 2023, 28(9): 969-978.

心血管疾病的时间治疗

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价